Cargando…

Folate functionalized pH-sensitive photothermal therapy traceable hollow mesoporous silica nanoparticles as a targeted drug carrier to improve the antitumor effect of doxorubicin in the hepatoma cell line SMMC-7721

In this paper, we prepared doxorubicin-loaded folic acid-functionalized pH-sensitive photothermal therapy (PTT) traceable hollow mesoporous silica nanoparticles (DOX-HPCF) as a drug carrier for liver cancer treatment. According to TEM characterization, hollow mesoporous silica nanoparticles (HMSN) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yue, Wu, Chao, Liu, Ying, Hu, Lili, Shang, Wenjing, Gao, Zhanshan, Xia, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034047/
https://www.ncbi.nlm.nih.gov/pubmed/32009475
http://dx.doi.org/10.1080/10717544.2020.1718801
_version_ 1783499800085266432
author Cao, Yue
Wu, Chao
Liu, Ying
Hu, Lili
Shang, Wenjing
Gao, Zhanshan
Xia, Nan
author_facet Cao, Yue
Wu, Chao
Liu, Ying
Hu, Lili
Shang, Wenjing
Gao, Zhanshan
Xia, Nan
author_sort Cao, Yue
collection PubMed
description In this paper, we prepared doxorubicin-loaded folic acid-functionalized pH-sensitive photothermal therapy (PTT) traceable hollow mesoporous silica nanoparticles (DOX-HPCF) as a drug carrier for liver cancer treatment. According to TEM characterization, hollow mesoporous silica nanoparticles (HMSN) are monodispersed spherical particles with hollow structure. In vitro drug release experiments showed that HPCF exhibited pH-sensitive release. Cell uptake experiments showed that HPCF was successfully absorbed by SMMC-7721 cells. In addition, DOX-HPCF significantly inhibited the proliferation of SMMC-7721 cells, and the near-infrared (NIR) light group showed a more obvious inhibitory effect. In vivo anti-tumor experiments showed that DOX-HPCF-assisted PTT inhibited tumor growth significantly. Therefore, HPCF is a promising photothermotherapy carrier for the treatment of liver cancer.
format Online
Article
Text
id pubmed-7034047
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-70340472020-03-03 Folate functionalized pH-sensitive photothermal therapy traceable hollow mesoporous silica nanoparticles as a targeted drug carrier to improve the antitumor effect of doxorubicin in the hepatoma cell line SMMC-7721 Cao, Yue Wu, Chao Liu, Ying Hu, Lili Shang, Wenjing Gao, Zhanshan Xia, Nan Drug Deliv Research Article In this paper, we prepared doxorubicin-loaded folic acid-functionalized pH-sensitive photothermal therapy (PTT) traceable hollow mesoporous silica nanoparticles (DOX-HPCF) as a drug carrier for liver cancer treatment. According to TEM characterization, hollow mesoporous silica nanoparticles (HMSN) are monodispersed spherical particles with hollow structure. In vitro drug release experiments showed that HPCF exhibited pH-sensitive release. Cell uptake experiments showed that HPCF was successfully absorbed by SMMC-7721 cells. In addition, DOX-HPCF significantly inhibited the proliferation of SMMC-7721 cells, and the near-infrared (NIR) light group showed a more obvious inhibitory effect. In vivo anti-tumor experiments showed that DOX-HPCF-assisted PTT inhibited tumor growth significantly. Therefore, HPCF is a promising photothermotherapy carrier for the treatment of liver cancer. Taylor & Francis 2020-02-03 /pmc/articles/PMC7034047/ /pubmed/32009475 http://dx.doi.org/10.1080/10717544.2020.1718801 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Cao, Yue
Wu, Chao
Liu, Ying
Hu, Lili
Shang, Wenjing
Gao, Zhanshan
Xia, Nan
Folate functionalized pH-sensitive photothermal therapy traceable hollow mesoporous silica nanoparticles as a targeted drug carrier to improve the antitumor effect of doxorubicin in the hepatoma cell line SMMC-7721
title Folate functionalized pH-sensitive photothermal therapy traceable hollow mesoporous silica nanoparticles as a targeted drug carrier to improve the antitumor effect of doxorubicin in the hepatoma cell line SMMC-7721
title_full Folate functionalized pH-sensitive photothermal therapy traceable hollow mesoporous silica nanoparticles as a targeted drug carrier to improve the antitumor effect of doxorubicin in the hepatoma cell line SMMC-7721
title_fullStr Folate functionalized pH-sensitive photothermal therapy traceable hollow mesoporous silica nanoparticles as a targeted drug carrier to improve the antitumor effect of doxorubicin in the hepatoma cell line SMMC-7721
title_full_unstemmed Folate functionalized pH-sensitive photothermal therapy traceable hollow mesoporous silica nanoparticles as a targeted drug carrier to improve the antitumor effect of doxorubicin in the hepatoma cell line SMMC-7721
title_short Folate functionalized pH-sensitive photothermal therapy traceable hollow mesoporous silica nanoparticles as a targeted drug carrier to improve the antitumor effect of doxorubicin in the hepatoma cell line SMMC-7721
title_sort folate functionalized ph-sensitive photothermal therapy traceable hollow mesoporous silica nanoparticles as a targeted drug carrier to improve the antitumor effect of doxorubicin in the hepatoma cell line smmc-7721
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034047/
https://www.ncbi.nlm.nih.gov/pubmed/32009475
http://dx.doi.org/10.1080/10717544.2020.1718801
work_keys_str_mv AT caoyue folatefunctionalizedphsensitivephotothermaltherapytraceablehollowmesoporoussilicananoparticlesasatargeteddrugcarriertoimprovetheantitumoreffectofdoxorubicininthehepatomacelllinesmmc7721
AT wuchao folatefunctionalizedphsensitivephotothermaltherapytraceablehollowmesoporoussilicananoparticlesasatargeteddrugcarriertoimprovetheantitumoreffectofdoxorubicininthehepatomacelllinesmmc7721
AT liuying folatefunctionalizedphsensitivephotothermaltherapytraceablehollowmesoporoussilicananoparticlesasatargeteddrugcarriertoimprovetheantitumoreffectofdoxorubicininthehepatomacelllinesmmc7721
AT hulili folatefunctionalizedphsensitivephotothermaltherapytraceablehollowmesoporoussilicananoparticlesasatargeteddrugcarriertoimprovetheantitumoreffectofdoxorubicininthehepatomacelllinesmmc7721
AT shangwenjing folatefunctionalizedphsensitivephotothermaltherapytraceablehollowmesoporoussilicananoparticlesasatargeteddrugcarriertoimprovetheantitumoreffectofdoxorubicininthehepatomacelllinesmmc7721
AT gaozhanshan folatefunctionalizedphsensitivephotothermaltherapytraceablehollowmesoporoussilicananoparticlesasatargeteddrugcarriertoimprovetheantitumoreffectofdoxorubicininthehepatomacelllinesmmc7721
AT xianan folatefunctionalizedphsensitivephotothermaltherapytraceablehollowmesoporoussilicananoparticlesasatargeteddrugcarriertoimprovetheantitumoreffectofdoxorubicininthehepatomacelllinesmmc7721